Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations
Apr 03
Polish (WIG) Clinical Research and Equipment Industry Analysis
UpdatedApr 18, 2024
DataAggregated Company Financials
Companies5
- 7D-1.6%
- 3M1.7%
- 1Y-9.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 2.1%, driven by gains from Selvita of 5.2%. However, the industry is down 7.7% over the past year. Looking forward, earnings are forecast to grow by 1.2% annually.
Industry Valuation and Performance
Has the Polish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 18 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 18.2x | -97.8x | 6.1x |
| Sat, 16 Mar 2024 | zł2.6b | zł478.9m | -zł71,866,957.00 | 46.3x | -35.8x | 5.4x |
| Mon, 12 Feb 2024 | zł2.5b | zł494.7m | -zł51,178,957.00 | 44.4x | -49.6x | 5.1x |
| Wed, 10 Jan 2024 | zł2.4b | zł495.2m | -zł50,454,191.00 | 44x | -48.3x | 4.9x |
| Fri, 08 Dec 2023 | zł2.5b | zł495.2m | -zł50,483,342.00 | 44.3x | -49.1x | 5x |
| Sun, 05 Nov 2023 | zł2.5b | zł512.0m | -zł37,354,934.00 | 31.1x | -66.6x | 4.9x |
| Tue, 03 Oct 2023 | zł2.8b | zł515.2m | -zł42,853,934.00 | 39.4x | -64.8x | 5.4x |
| Thu, 31 Aug 2023 | zł2.7b | zł507.8m | -zł51,598,105.00 | 43.2x | -52.9x | 5.4x |
| Sat, 29 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 45.9x | -46.1x | 5.5x |
| Mon, 26 Jun 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 43.9x | -45.4x | 5.5x |
| Wed, 24 May 2023 | zł2.9b | zł507.5m | -zł59,821,034.00 | 47x | -48.7x | 5.7x |
| Fri, 21 Apr 2023 | zł2.9b | zł505.4m | -zł64,921,034.00 | 68.2x | -44.1x | 5.7x |
| Sun, 19 Mar 2023 | zł3.1b | zł473.8m | -zł77,860,781.00 | 77.6x | -40.2x | 6.6x |
| Tue, 14 Feb 2023 | zł2.9b | zł475.0m | -zł78,933,423.00 | 84.8x | -37.2x | 6.2x |
| Thu, 12 Jan 2023 | zł3.0b | zł483.0m | -zł79,277,613.00 | 60.7x | -37.9x | 6.2x |
| Sat, 10 Dec 2022 | zł2.6b | zł466.1m | -zł87,326,946.00 | 155x | -30.3x | 5.7x |
| Mon, 07 Nov 2022 | zł2.4b | zł445.7m | -zł96,033,392.00 | 59.4x | -24.6x | 5.3x |
| Wed, 05 Oct 2022 | zł2.4b | zł443.7m | -zł83,357,892.00 | 63.5x | -28.2x | 5.3x |
| Fri, 02 Sep 2022 | zł2.0b | zł409.8m | -zł84,484,453.00 | 58.6x | -23.7x | 4.9x |
| Sun, 31 Jul 2022 | zł2.0b | zł417.3m | -zł76,832,012.00 | 55.4x | -26.5x | 4.9x |
| Tue, 28 Jun 2022 | zł1.7b | zł417.3m | -zł76,832,012.00 | 50.8x | -22.7x | 4.2x |
| Thu, 26 May 2022 | zł2.0b | zł392.6m | -zł74,127,317.00 | 47.1x | -26.8x | 5.1x |
| Sat, 23 Apr 2022 | zł2.3b | zł383.1m | -zł63,046,404.00 | 51.9x | -37x | 6.1x |
| Mon, 21 Mar 2022 | zł2.2b | zł327.3m | -zł66,400,347.00 | 55.3x | -32.4x | 6.6x |
| Wed, 16 Feb 2022 | zł2.4b | zł310.5m | -zł60,441,559.00 | 63.3x | -40.4x | 7.9x |
| Fri, 14 Jan 2022 | zł2.8b | zł310.5m | -zł60,562,303.00 | 71x | -46x | 9x |
| Sun, 12 Dec 2021 | zł2.8b | zł310.5m | -zł60,562,303.00 | 70.5x | -45.8x | 8.9x |
| Tue, 09 Nov 2021 | zł2.8b | zł256.7m | -zł41,621,781.00 | 44.6x | -67.7x | 11x |
| Thu, 07 Oct 2021 | zł2.5b | zł256.8m | -zł40,525,424.00 | 39.9x | -62.4x | 9.8x |
| Sat, 04 Sep 2021 | zł2.6b | zł222.6m | -zł34,840,889.00 | 31.5x | -73.9x | 11.6x |
| Mon, 02 Aug 2021 | zł2.7b | zł222.6m | -zł34,840,889.00 | 34.8x | -76.8x | 12x |
| Thu, 06 May 2021 | zł2.5b | zł218.1m | -zł20,057,453.00 | 49.5x | -125.4x | 11.5x |
Price to Earnings Ratio
-125.4x
Current Industry PE
- Investors are relatively neutral on the Polish Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 25% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Polish Clinical Research and Equipment compare with similar industries?
| PL Market | -3.07% | |
| Healthcare | -1.92% | |
| Life Sciences | -1.64% | |
| Clinical Research and Equipment | -1.64% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł69.10 | 1.3% +zł16.5m | -10.3% | PE18.2x |